Rezolute (RZLT) Depreciation & Amortization (CF) (2014 - 2026)
Rezolute (RZLT) reported Depreciation & Amortization (CF) of $8000.0 for Q1 2026, up 14.29% on a YoY basis from $7000.0 in Q1 2025, and up 14.29% sequentially from $7000.0 in Q4 2025.
Rezolute (RZLT) Depreciation & Amortization (CF) (2014 - 2026) Analysis & Trends
Rezolute (RZLT) has 13 years of Depreciation & Amortization (CF) data on file, last reported at $8000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 14.29% year-over-year to $8000.0; the trailing twelve-month figure through Mar 2026 stood at $31000.0 (up 3.33% YoY), and the FY2025 full-year result was $31000.0, down 13.89% from the prior year.
- Depreciation & Amortization (CF) grew to $8000.0 in Q1 2026, from $7000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $11000.0 in Q1 2023 to a low of $3000.0 in Q1 2022.
- A 5-year average of $7411.8 and a median of $8000.0 in 2024 frame the typical range for Depreciation & Amortization (CF).
- Across the five-year window, Depreciation & Amortization (CF) retreated 25.0% in 2022 and surged 266.67% in 2023, its largest moves.
- Tracing RZLT's Depreciation & Amortization (CF) over 5 years: stood at $7000.0 in 2022, then jumped by 42.86% to $10000.0 in 2023, then fell by 20.0% to $8000.0 in 2024, then dropped by 12.5% to $7000.0 in 2025, then advanced by 14.29% to $8000.0 in 2026.
- Business Quant data shows RZLT's Depreciation & Amortization (CF) at $8000.0 in Q1 2026, $7000.0 in Q4 2025, and $8000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 41.14 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 2.20 Mn |
| 10 | Rezolute | 518.12 Mn | 518.12 Mn | - | 8,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8,000.00 |
| Mar 31, 2026 | 8,000.00 |
| Dec 31, 2025 | 7,000.00 |
| Dec 31, 2025 | 7,000.00 |
| Sep 30, 2025 | 8,000.00 |
| Sep 30, 2025 | 8,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Dec 31, 2024 | 8,000.00 |
| Dec 31, 2024 | 8,000.00 |
| Sep 30, 2024 | 8,000.00 |
| Sep 30, 2024 | 8,000.00 |
| Jun 30, 2024 | 7,000.00 |
| Jun 30, 2024 | 7,000.00 |
| Mar 31, 2024 | 9,000.00 |
| Mar 31, 2024 | 9,000.00 |
| Dec 31, 2023 | 10,000.00 |
| Dec 31, 2023 | 10,000.00 |